Brahmaiah Kommanaboyina

Brahmaiah Kommanaboyina is an experienced regulatory affairs professional with an extensive background in the pharmaceutical industry. Currently, Brahmaiah serves as the Executive Director and Head of Regulatory Affairs at Jiangsu Hengrui Pharmaceuticals Co., Ltd. and has previously held significant leadership roles including Vice President of Scientific Affairs at Sagent Pharmaceuticals and Director of Regulatory Affairs at Akorn, Inc. Additionally, experience includes managing global regulatory CMC at Baxter International Inc. and providing freelance regulatory affairs services. Brahmaiah holds a Master of Science in Applied Pharmaceutical Sciences from the University of Rhode Island and a Master of Pharmacy in Pharmaceutics and Drug Design from the Birla Institute of Technology and Science, Pilani.